Shimadzu
Shimadzu Corporation specializes in manufacturing scientific instruments and operates across four main segments: analytical and measuring instruments, medical systems, aircraft equipment, and industrial machinery. The analytical and measuring instruments segment is known for producing key devices such as chromatograph mass spectrometers, surface analyzers, and environmental measurement instruments, which are essential for research and quality control in the pharmaceutical, chemical, and life sciences industries. The medical systems segment offers diagnostic imaging equipment tailored for hospitals and medical offices. In the aircraft equipment segment, Shimadzu supplies air-conditioning systems, flight control systems, and displays, while its industrial machinery segment provides various products to major manufacturing sectors. Through its diverse portfolio, Shimadzu plays a significant role in advancing scientific research and technological development.
Rege Nephro Co., Ltd. engages in the research and development, production, and marketing of renal disease therapeutics using nephron progenitor cells. It also produces kidney organoids capable of nephrotoxicity screening for drug discovery in applied research. The company was founded in 2019 and is based in Kyoto, Japan.
iLAC Inc. specializes in personalized precision medicine, focusing on advanced genome sequencing to decode the nucleotide sequences of genes. The company, incorporated in 2012 and based in Tsukuba, Japan, utilizes cutting-edge technology to diagnose diseases based on scientific evidence. By leveraging its expertise in genome analysis, iLAC aims to improve disease detection and treatment, contributing to the evolving field of precision medicine.
Molecular and Clinical Bioinformatics is a Bioinformatics company.
Alsachim SAS is a contract research and development service provider based in Illkirch-Graffenstaden, France, specializing in stable isotope-labeled compounds and pharmaceutical-related substances. Established in 2005, the company offers custom synthesis services for a variety of products, including pharmaceutical active organic compounds, metabolites, peptides, and isotopically-labeled reference standards. Alsachim also provides analytical services, such as certificates of analysis detailing chemical purity and storage conditions, along with compound certification and re-analysis. Its product offerings include stable isotopes, drugs, metabolites, pesticides, and mass spectrometry kits, catering to a diverse clientele that spans the pharmaceutical and biotech industries, clinical and bio-analytical contract research organizations, and research institutions. Alsachim SAS operates as a subsidiary of Shimadzu Europa GmbH since June 2017.
iPS PORTAL, Inc., founded in 2014 and based in Kyoto, Japan, specializes in the development of instruments for analyzing and measuring cells. The company focuses on contract testing of induced pluripotent stem (iPS) cells, aiming to promote the widespread adoption of iPS cell technology. iPS PORTAL provides research and development outsourcing services that support the practical application of iPS cell technology. Its offerings include assistance in research, contract testing, development, concept planning, and training programs in cell culture for researchers. By facilitating these services, iPS PORTAL enables healthcare companies to enhance research efforts and expedite the commercialization of drug discovery and regenerative medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.